https://www.marketscreener.com/quote/stock/AMGEN-INC-4847/news/Amgen-European-Commission-Approves-EVENITY-romosozumab-For-The-Treatment-Of-Severe-Osteoporosi-29716593/?utm_source=telegram&utm_medium=social&utm_campaign=share